Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
Profitability Metrics
Gross Margin
49.15%
Operating Margin
29.00%
Net Margin
20.56%
Efficiency Metrics
Revenue per Expense Ratio
1.45
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
47.91%
Income Tax Rate
17.72%
EPS
224.5900000000
Balance Sheet Analysis
Current Ratio
0.72
Cash Ratio
0.00
Working Capital
$-1.67B
Debt to Equity
0.88
Debt to Assets
33.27%
Equity Ratio
37.63%
Cash Flow Analysis
Operating Cash Flow Ratio
27.20%
Free Cash Flow Ratio
-20.10%
CapEx to Revenue
47.30%
Dividends Paid
$1.86B
Stock Buybacks
No buybacks
Total Shareholder Returns
$1.86B
Cash Position Change
-84.38%
Key Takeaways (2023 FY)
Revenue declined by 65.4428088391%, indicating potential market challenges
Increased dividend payments by 9.70%
Detailed Growth Metrics
Core Performance
Revenue
-65.44%
Net Income
-39.32%
EPS
-39.32%
Operating Income
-53.73%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-13.27%
Operating Cash Flow
35.03%
Free Cash Flow
-14.85%
Balance Sheet Health
Assets
6.87%
Debt
8.99%
Book Value per Share
13.39%
Inventory
33.63%
Shareholder Returns
Dividends per Share
9.70%
Shares Outstanding
0.00%
Long Term Trends
3Y Revenue/Share
21.77%
5Y Revenue/Share
20.17%
3Y Dividend/Share
20.30%
5Y Dividend/Share
32.88%